FI953916A0 - Fibrinogenreceptorantagonister - Google Patents

Fibrinogenreceptorantagonister

Info

Publication number
FI953916A0
FI953916A0 FI953916A FI953916A FI953916A0 FI 953916 A0 FI953916 A0 FI 953916A0 FI 953916 A FI953916 A FI 953916A FI 953916 A FI953916 A FI 953916A FI 953916 A0 FI953916 A0 FI 953916A0
Authority
FI
Finland
Prior art keywords
fibrinogen
Prior art date
Application number
FI953916A
Other languages
English (en)
Finnish (fi)
Other versions
FI953916A (sv
Inventor
David Alan Claremon
John J Baldwin
Nigel Liverton
Ben Askew
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI953916A publication Critical patent/FI953916A/sv
Publication of FI953916A0 publication Critical patent/FI953916A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI953916A 1993-02-22 1995-08-21 Fibrinogenreceptorantagonister FI953916A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051793A 1993-02-22 1993-02-22
PCT/US1994/001881 WO1994018981A1 (en) 1993-02-22 1994-02-22 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
FI953916A FI953916A (sv) 1995-08-21
FI953916A0 true FI953916A0 (sv) 1995-08-21

Family

ID=21799049

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953916A FI953916A0 (sv) 1993-02-22 1995-08-21 Fibrinogenreceptorantagonister

Country Status (15)

Country Link
EP (1) EP0684823A4 (sv)
JP (1) JP3173792B2 (sv)
KR (1) KR960700722A (sv)
CN (1) CN1118139A (sv)
AU (1) AU680240B2 (sv)
BG (1) BG99863A (sv)
CA (1) CA2155123A1 (sv)
CZ (1) CZ210895A3 (sv)
FI (1) FI953916A0 (sv)
HU (1) HUT71796A (sv)
NO (1) NO953270L (sv)
NZ (1) NZ262664A (sv)
PL (1) PL310386A1 (sv)
SK (1) SK102495A3 (sv)
WO (1) WO1994018981A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
AU702487B2 (en) * 1995-08-30 1999-02-25 G.D. Searle & Co. Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
US6291469B1 (en) 1995-09-29 2001-09-18 Eli Lilly And Company Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
JP2000501105A (ja) * 1995-12-22 2000-02-02 デュポン ファーマシューティカルズ カンパニー 新規なインテグリン受容体アンタゴニスト
AU2340997A (en) * 1996-03-27 1997-10-17 Merck & Co., Inc. A method for inhibiting clot formation
CZ298089B6 (cs) * 1996-07-25 2007-06-20 Biogen Idec Ma Inc. Inhibitory bunecné adheze, zpusob jejich prípravya farmaceutické prostredky s jejich obsahem
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists
DE19653647A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
EP1023295A4 (en) * 1997-02-06 2001-01-24 Merck & Co Inc PRODUCTS BY FIBRINOGEN RECEPTOR ANTAGONISTS
AU6780398A (en) * 1997-03-28 1998-10-22 Du Pont Merck Pharmaceutical Company, The Heterocyclic integrin inhibitor prodrugs
US6303625B1 (en) * 1998-07-27 2001-10-16 Ortho-Mcneil Pharmaceutical, Inc. Triazolopyridines for the treatment of thrombosis disorders
CN1420882A (zh) * 1999-07-28 2003-05-28 阿温蒂斯药物公司 取代的氧代氮杂杂环基化合物
MXPA05006569A (es) * 2002-12-20 2005-09-22 Pharmacia Corp Compuestos que inhiben la proteina cinasa-2 activada por la proteina cinasa activada por el mitogeno.
CA2656855A1 (en) * 2006-07-12 2008-01-17 Christoph Luthy Triazolopyridine derivatives as herbicides
BRPI0910987A2 (pt) * 2008-04-04 2017-03-21 Gilead Sciences Inc derivados de triazolopiridinona para uso como inibidores de estearoil-coa dessaturase
WO2010096722A1 (en) * 2009-02-20 2010-08-26 Takeda Pharmaceutical Company Limited 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5166154A (en) * 1989-10-17 1992-11-24 Boehringer Ingelheim Pharmaceuticals, Inc. Imidazo[1,2-a]piperazines
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors

Also Published As

Publication number Publication date
CN1118139A (zh) 1996-03-06
HU9502028D0 (en) 1995-09-28
FI953916A (sv) 1995-08-21
WO1994018981A1 (en) 1994-09-01
NO953270D0 (no) 1995-08-21
SK102495A3 (en) 1997-01-08
PL310386A1 (en) 1995-12-11
HUT71796A (en) 1996-02-28
AU680240B2 (en) 1997-07-24
JPH08507072A (ja) 1996-07-30
NO953270L (no) 1995-10-19
EP0684823A4 (en) 1997-07-09
JP3173792B2 (ja) 2001-06-04
CA2155123A1 (en) 1994-09-01
CZ210895A3 (en) 1996-02-14
EP0684823A1 (en) 1995-12-06
BG99863A (en) 1996-02-29
NZ262664A (en) 1997-04-24
AU6246594A (en) 1994-09-14
KR960700722A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
ITMI931780A0 (it) Tropil 7-azaindol-3-ilcarbossiamidi
FI953916A0 (sv) Fibrinogenreceptorantagonister
FI940154A (sv) Substituerade dialkyltioetrar
FI950586A (sv) Aminosyraderivat
DE59403503D1 (de) Substituierte 1-Aryltriazolinone
FI932094A0 (fi) Kylningsapparat i kranens vaexel
FI932732A0 (fi) Rotorkonstruktion i en tvaolindningselektricitetsmaskin
NO941150D0 (no) Tiadiazinoner
FI955559A0 (sv) Bensotiofenkarboxylsyraamid-S-oxider
FI940809A0 (sv) Oligomeringsförfarande
FI932264A0 (fi) Gapformare i en pappersmaskin
FI961101A (sv) Vakuumvalsanordning
BR9405830A (pt) Oxazois substituidos
FI930927A0 (fi) Banformningsparti i en pappersmaskin
FI833U1 (fi) Dammfilter foer vaedringsluckor i foenster
FI1435U1 (fi) Foer synskadande avsett hjaelpdon i elspisvred
FI935503A0 (fi) Elmotstaond i en sotlucka
FI933617A0 (fi) Anordning i en stoetborrmaskin
SE9301675D0 (sv) Stensberg i
FI933406A0 (fi) Glidyta foer farttagningsspaor i hoppbacke
FI931520A0 (fi) Saekerhetssystem foer elspisar i hemhushaoll
FI934019A0 (fi) Foerfarande foer stoerningsmaetning i en basstation
FI932109A0 (fi) Maetningselement i en givare
FI934136A0 (fi) Lastoeverfoeringsanordning i vaexelflak
FI932892A0 (fi) Samtalsdirigeringsfoerfarande i mobilnaet

Legal Events

Date Code Title Description
FD Application lapsed